Company intelligence / Profile preview

ProVen Probiotics

Port Talbot, Wales, United Kingdom

Ownership: Private
Employees: ~10
Development stage: Other

Overview

ProVen Probiotics' products are supported by a large body of research, including over 40 published scientific papers and at least 24 double-blind, placebo-controlled clinical studies showing benefits in digestive and immune health, allergy, and other indications in diverse populations, from pregnancy through adulthood[1][3][9].

Therapeutic areas: ImmunologyCardiovascularGastroenterologyInfectious DiseasesOtherDermatology
Modalities: Live biotherapeutic product therapyProbiotic supplement
Industry: Food & Nutrition

Partnerships

Addenbrooke’s Hospital, Cambridge (clinical trials collaboration)Swansea University (clinical trials collaboration)Other major hospitals and universities (clinical research)

Beyond the preview

Go deeper on ProVen Probiotics.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on ProVen Probiotics.

Explore the full profile